Eculizumab: A Review of its Use in Paroxysmal Nocturnal Haemoglobinuria

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.17, 2011-12, pp. : 2327-2345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eculizumab for paroxysmal nocturnal haemoglobinuria

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 513, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Eculizumab for paroxysmal nocturnal haemoglobinuria

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Eculizumab in Paroxysmal Nocturnal Haemoglobinuria

By Charneski Lisa

Drugs, Vol. 68, Iss. 10, 2008-01 ,pp. : 1341-1346

Adis International

Access to resources Recommend Favorite

Eculizumab reduces the risk of thromboembolism in patients with paroxysmal nocturnal haemoglobinuria

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Chloramphenicol: Paroxysmal nocturnal haemoglobinuria in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1091, 2006-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite